The company wrote down $410 million in acquired research and development assets, indicating a significant R&D project or acquisition has failed to meet expectations. This financial loss highlights potential gaps in their R&D pipeline evaluation and integration processes.
Filing excerpt
Research and development expense increased by $393 million in the first quarter of 2026, primarily due to IPRD impairment charges of $410 million, partially offset by cost savings from the Company's ongoing strategic productivity initiative.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qgoodwillImpairmentGet every 10-Q signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/11b14a89-e8f9-416a-8330-af73930bc525 returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.
{
"signal_id": "11b14a89-e8f9-416a-8330-af73930bc525",
"signal_type": "sec-10q",
"signal_subtype": "goodwillImpairment",
"detected_at": "2026-05-05T08:48:21.337+00:00",
"company": {
"name": "Bristol Myers Squibb",
"domain": "bms.com"
},
"data": {
"detail": "The company wrote down $410 million in acquired research and development assets, indicating a significant R&D project or acquisition has failed to meet expectations. This financial loss highlights potential gaps in their R&D pipeline evaluation and integration processes.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "IPRD impairment charges",
"dollar_millions": 410
},
"summary": "Took a $410M impairment charge on In-Process R&D (IPRD) in Q1 2026",
"excerpts": "Research and development expense increased by $393 million in the first quarter of 2026, primarily due to IPRD impairment charges of $410 million, partially offset by cost savings from the Company's ongoing strategic productivity initiative.",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/bmy-20260331.htm",
"filing_date": "2026-04-30",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Strategic review underway",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/11b14a89-e8f9-416a-8330-af73930bc525 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bms.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.